Clinical immunophenotype of nasopharyngeal neuroendocrine carcinoma with metastatic liver cancer.
Nasopharyngeal neuroendocrine carcinoma (NNC) refers to a rare and lethal cancer, characterized with high risk of metastases. Here, we report a case of nasopharyngeal neuroendocrine carcinoma with subsequent liver metastases to discuss its clinical immunophenotype and challenges. In clinical biochemical assays, hematological determination, immunohistochemical examination, imaging medicine investigations, and therapeutical analysis were subjected to the hospitalized patient, respectively. A group of clinical detectable data highlighted that clinical immunophenotype of nasopharyngeal neuroendocrine carcinoma was identified in immunohistochemical inspection, followed by validation of liver metastases via imaging observations. Subsequent chemotherapy schedule showed disease remission in certain aspect before patient' death. Our current clinical data disclose that it is vital to identify nasopharyngeal neuroendocrine carcinoma for main cause of liver metastases with potential risk. Further, early diagnosis and effective pharmacotherapy may improve the survival rate of NNC patient with liver metastases.